657 related articles for article (PubMed ID: 8998183)
1. Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma.
Gasparini G; Toi M; Gion M; Verderio P; Dittadi R; Hanatani M; Matsubara I; Vinante O; Bonoldi E; Boracchi P; Gatti C; Suzuki H; Tominaga T
J Natl Cancer Inst; 1997 Jan; 89(2):139-47. PubMed ID: 8998183
[TBL] [Abstract][Full Text] [Related]
2. Thrombospondin-1 and -2 in node-negative breast cancer: correlation with angiogenic factors, p53, cathepsin D, hormone receptors and prognosis.
Gasparini G; Toi M; Biganzoli E; Dittadi R; Fanelli M; Morabito A; Boracchi P; Gion M
Oncology; 2001; 60(1):72-80. PubMed ID: 11150912
[TBL] [Abstract][Full Text] [Related]
3. Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapy.
Gasparini G; Toi M; Miceli R; Vermeulen PB; Dittadi R; Biganzoli E; Morabito A; Fanelli M; Gatti C; Suzuki H; Tominaga T; Dirix LY; Gion M
Cancer J Sci Am; 1999; 5(2):101-11. PubMed ID: 10198732
[TBL] [Abstract][Full Text] [Related]
4. Correlation of vascular endothelial growth factor content with recurrences, survival, and first relapse site in primary node-positive breast carcinoma after adjuvant treatment.
Linderholm B; Grankvist K; Wilking N; Johansson M; Tavelin B; Henriksson R
J Clin Oncol; 2000 Apr; 18(7):1423-31. PubMed ID: 10735889
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of vascular endothelial growth factor in breast cancer.
Gasparini G
Oncologist; 2000; 5 Suppl 1():37-44. PubMed ID: 10804090
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor is of high prognostic value in node-negative breast carcinoma.
Linderholm B; Tavelin B; Grankvist K; Henriksson R
J Clin Oncol; 1998 Sep; 16(9):3121-8. PubMed ID: 9738584
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor (VEGF) in human breast cancer: correlation with disease-free survival.
Obermair A; Kucera E; Mayerhofer K; Speiser P; Seifert M; Czerwenka K; Kaider A; Leodolter S; Kainz C; Zeillinger R
Int J Cancer; 1997 Aug; 74(4):455-8. PubMed ID: 9291439
[TBL] [Abstract][Full Text] [Related]
8. Does vascular endothelial growth factor (VEGF) predict local relapse and survival in radiotherapy-treated node-negative breast cancer?
Linderholm B; Tavelin B; Grankvist K; Henriksson R
Br J Cancer; 1999 Oct; 81(4):727-32. PubMed ID: 10574263
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of vascular endothelial growth factor D in breast carcinoma with long-term follow-up.
Nakamura Y; Yasuoka H; Tsujimoto M; Yang Q; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K
Clin Cancer Res; 2003 Feb; 9(2):716-21. PubMed ID: 12576440
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value of vascular endothelial growth factor in 574 node-negative breast cancer patients who did not receive adjuvant systemic therapy.
Manders P; Beex LV; Tjan-Heijnen VC; Geurts-Moespot J; Van Tienoven TH; Foekens JA; Sweep CG
Br J Cancer; 2002 Sep; 87(7):772-8. PubMed ID: 12232762
[TBL] [Abstract][Full Text] [Related]
11. High tumor levels of vascular endothelial growth factor predict poor response to systemic therapy in advanced breast cancer.
Foekens JA; Peters HA; Grebenchtchikov N; Look MP; Meijer-van Gelder ME; Geurts-Moespot A; van der Kwast TH; Sweep CG; Klijn JG
Cancer Res; 2001 Jul; 61(14):5407-14. PubMed ID: 11454684
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor expression in early stage ovarian carcinoma.
Paley PJ; Staskus KA; Gebhard K; Mohanraj D; Twiggs LB; Carson LF; Ramakrishnan S
Cancer; 1997 Jul; 80(1):98-106. PubMed ID: 9210714
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of vascular endothelial growth factor protein levels in oral and oropharyngeal squamous cell carcinoma.
Smith BD; Smith GL; Carter D; Sasaki CT; Haffty BG
J Clin Oncol; 2000 May; 18(10):2046-52. PubMed ID: 10811669
[TBL] [Abstract][Full Text] [Related]
14. VEGF, flt-1, and KDR/flk-1 as prognostic indicators in endometrial carcinoma.
Fine BA; Valente PT; Feinstein GI; Dey T
Gynecol Oncol; 2000 Jan; 76(1):33-9. PubMed ID: 10620438
[TBL] [Abstract][Full Text] [Related]
15. Endogenous interleukin-12: relationship with angiogenic factors, hormone receptors and nodal status in human breast carcinoma.
Toi M; Gion M; Saji H; Asano M; Dittadi R; Gilberti S; Locopo N; Gasparini G
Int J Oncol; 1999 Dec; 15(6):1169-75. PubMed ID: 10568824
[TBL] [Abstract][Full Text] [Related]
16. [Tumor angiogenesis in node-negative breast carcinoma].
Li HJ; Jing J; Zhao YB; Zhu JQ; Zhang SY; Shi ZD
Ai Zheng; 2002 Jan; 21(1):75-8. PubMed ID: 12500403
[TBL] [Abstract][Full Text] [Related]
17. p53 and vascular-endothelial-growth-factor (VEGF) expression predicts outcome in 833 patients with primary breast carcinoma.
Linderholm B; Lindh B; Tavelin B; Grankvist K; Henriksson R
Int J Cancer; 2000 Jan; 89(1):51-62. PubMed ID: 10719731
[TBL] [Abstract][Full Text] [Related]
18. Markers of tumor angiogenesis and proteolysis independently define high- and low-risk subsets of node-negative breast cancer patients.
Eppenberger U; Kueng W; Schlaeppi JM; Roesel JL; Benz C; Mueller H; Matter A; Zuber M; Luescher K; Litschgi M; Schmitt M; Foekens JA; Eppenberger-Castori S
J Clin Oncol; 1998 Sep; 16(9):3129-36. PubMed ID: 9738585
[TBL] [Abstract][Full Text] [Related]
19. An evaluation of the prognostic significance of vascular endothelial growth factor in node positive primary breast carcinoma.
MacConmara M; O'Hanlon DM; Kiely MJ; Connolly Y; Jeffers M; Keane FB
Int J Oncol; 2002 Apr; 20(4):717-21. PubMed ID: 11894115
[TBL] [Abstract][Full Text] [Related]
20. Significance of vascular endothelial growth factor (VEGF)/soluble VEGF receptor-1 relationship in breast cancer.
Toi M; Bando H; Ogawa T; Muta M; Hornig C; Weich HA
Int J Cancer; 2002 Mar; 98(1):14-8. PubMed ID: 11857378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
